WINSTON-SALEM, NC (Wake Forest University Media Relations) – Regenerative medicine manufacturing in space is the next frontier and will be possible due to a new three-way partnership between Axiom Space, which is building the world’s first commercial space station, the RegenMed Development Organization (ReMDO), the first organization dedicated to advancing regenerative medicine manufacturing scale-up and automation, and the Wake Forest Institute of Regenerative Medicine (WFIRM), an international leader in translating scientific discovery into clinical therapies.

EDWARDS, Calif. (NASA PR) — Following successful Flight Opportunities-supported parabolic flight testing on Zero Gravity Corporation’s G-FORCE ONE aircraft in April and May, 2021, the Ring-Sheared Drop (RSD) experiment from NASA’s Marshall Space Flight Center arrived at the International Space Station on Northrop Grumman’s NG-16 Cygnus spacecraft on August 12, 2021.

by Nicole Quenelle
NASA’s Armstrong Flight Research Center

Rocket off course? It could be a slosh problem.

Propellant slosh, to be exact. The motion of propellant inside a rocket-based launch vehicle or spacecraft tank is an ever-present, vexing problem for spaceflight. Not only can it make gauging the amount of available propellant difficult, but the volatile waves of liquid can literally throw a rocket off its trajectory.

KENNEDY SPACE CENTER, Fla. (CASIS PR) — SpaceX’s 21^st commercial resupply mission (CRS-21) to the International Space Station (ISS) is slated for launch on December 5 at 11:39 a.m. EST from Launch Pad 39A at Kennedy Space Center in Florida.

The ISS U.S. National Laboratory is sponsoring more than 15 payloads on this mission that will bring value to our nation and further enable a sustainable market in low Earth orbit.

KENNEDY SPACE CENTER (FL), August 12, 2019 (ISS U.S. National Laboratory PR) – The International Space Station (ISS) U.S. National Laboratory is embarking upon a multi-year research alliance with the McGowan Institute for Regenerative Medicine (MIRM) at the University of Pittsburgh (Pitt) to push the limits of biomedical research and development aboard the orbiting laboratory.

Astronaut Shannon Walker activates an experiment aboard the International Space Station. Image credit: NASA

AUSTIN, Texas, Feb. 8, 2012 (Astrogenetix PR) — Astrogenetix Corporation, a subsidiary of Astrotech Corporation (Nasdaq:ASTC – News), has entered into a Space Act Agreement (SAA) with NASA, (National Aeronautics and Space Administration). This SAA commits to providing the critical resources needed to continue utilizing the International Space Station (ISS) and to further the development of important on-orbit microgravity vaccines and therapeutic drug experiments.

Astrogenetix entered into a similar SAA in 2009 resulting in 12 successful missions on the Space Shuttle that led to the discovery of potential vaccine targets for both salmonella and MRSA. This experience clearly identified that the most important part of the discovery process is the repeated frequency of access to microgravity. The new SAA reflects this important priority and NASA has committed to provide a minimum of 28 missions between 2013 and 2016.

(more…)

International Space Station

New Biology Research to Run on Space Station
Space.com

The International Space Station is about to take one giant leap for biological science in orbit.

Three new biomedical experiments funded by the U.S. National Institutes of Health will take advantage of the space station’s unique orbital facilities and weightless environment, NASA officials said. The experiments will use the station as a lab to study how bones and the immune system weaken in space.

(more…)